Interestingly, these elevated circulating levels of FGF21 have been highlighted in NAFLD patients by a meta-analysis where the levels of FGF21 showed one of the best sensitivities to segregate NASH from steatosis patients68. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.